Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)

Lymph‐Directed Drug Delivery In article number 2101935, Jihoon Kim, Won Jong Kim, and co‐workers introduce an albumin‐conjugated self‐immolative nitric oxide (NO) prodrug to achieve lymph‐directed NO delivery for inhibition of tumor metastasis. This novel prodrug can contribute to the on‐demand deli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Taejeong, Suh, Jeeyeon, Kim, Jihoon, Kim, Won Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Inside Back Cover
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922128/
http://dx.doi.org/10.1002/advs.202270050
_version_ 1784669465567297536
author Kim, Taejeong
Suh, Jeeyeon
Kim, Jihoon
Kim, Won Jong
author_facet Kim, Taejeong
Suh, Jeeyeon
Kim, Jihoon
Kim, Won Jong
author_sort Kim, Taejeong
collection PubMed
description Lymph‐Directed Drug Delivery In article number 2101935, Jihoon Kim, Won Jong Kim, and co‐workers introduce an albumin‐conjugated self‐immolative nitric oxide (NO) prodrug to achieve lymph‐directed NO delivery for inhibition of tumor metastasis. This novel prodrug can contribute to the on‐demand delivery of NO for biomedical applications. [Image: see text]
format Online
Article
Text
id pubmed-8922128
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89221282022-03-21 Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022) Kim, Taejeong Suh, Jeeyeon Kim, Jihoon Kim, Won Jong Adv Sci (Weinh) Inside Back Cover Lymph‐Directed Drug Delivery In article number 2101935, Jihoon Kim, Won Jong Kim, and co‐workers introduce an albumin‐conjugated self‐immolative nitric oxide (NO) prodrug to achieve lymph‐directed NO delivery for inhibition of tumor metastasis. This novel prodrug can contribute to the on‐demand delivery of NO for biomedical applications. [Image: see text] John Wiley and Sons Inc. 2022-03-15 /pmc/articles/PMC8922128/ http://dx.doi.org/10.1002/advs.202270050 Text en © 2022 Wiley‐VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Inside Back Cover
Kim, Taejeong
Suh, Jeeyeon
Kim, Jihoon
Kim, Won Jong
Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
title Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
title_full Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
title_fullStr Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
title_full_unstemmed Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
title_short Lymph‐Directed Self‐Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer (Adv. Sci. 8/2022)
title_sort lymph‐directed self‐immolative nitric oxide prodrug for inhibition of intractable metastatic cancer (adv. sci. 8/2022)
topic Inside Back Cover
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922128/
http://dx.doi.org/10.1002/advs.202270050
work_keys_str_mv AT kimtaejeong lymphdirectedselfimmolativenitricoxideprodrugforinhibitionofintractablemetastaticcanceradvsci82022
AT suhjeeyeon lymphdirectedselfimmolativenitricoxideprodrugforinhibitionofintractablemetastaticcanceradvsci82022
AT kimjihoon lymphdirectedselfimmolativenitricoxideprodrugforinhibitionofintractablemetastaticcanceradvsci82022
AT kimwonjong lymphdirectedselfimmolativenitricoxideprodrugforinhibitionofintractablemetastaticcanceradvsci82022

Ejemplares similares